As of this week both the Senate and House of Representatives have passed a new bill called the Right to Try Act that would allow certain patients the ability to try medication that has not yet been approved by the FDA. For a patient to qualify for the program they must have a "potentially fatal condition" and while no specific conditions were listed many states already have similar laws in place that would further define these conditions. The Right to Try Act does not allow patients access to anything, only medications that are currently in the process of being approved by the FDA, which in this case includes medical marijuana. Trump has already tweeted his support for the bill and is expected to sign it soon.
While the bill’s provisions are targeted at a wide range of medications, it appears they might also apply to medical cannabis thanks to a clinical trial being conducted by the Multidisciplinary Association of Psychedelic Sciences (MAPS).
The MAPS trial, currently in the second phase of the FDA approval process, is testing the effectiveness of smoked cannabis in veterans with PTSD and meets all of the criteria set out by the Right to Try.
Original article: https://herb.co/marijuana/news/trump-right-to-try-marijuana-cannabis